Motley Fool Wealth Management LLC Sells 4,406 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Motley Fool Wealth Management LLC decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 3.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 136,729 shares of the company’s stock after selling 4,406 shares during the quarter. Motley Fool Wealth Management LLC owned approximately 0.16% of HealthEquity worth $13,280,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Holocene Advisors LP acquired a new position in shares of HealthEquity during the third quarter worth approximately $1,246,000. HighTower Advisors LLC lifted its holdings in HealthEquity by 4.8% during the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company’s stock worth $9,122,000 after buying an additional 4,370 shares in the last quarter. Geneva Capital Management LLC boosted its position in HealthEquity by 24.6% in the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock valued at $100,642,000 after buying an additional 206,894 shares during the last quarter. BNP Paribas Financial Markets increased its stake in shares of HealthEquity by 165.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock valued at $1,673,000 after buying an additional 12,745 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in shares of HealthEquity by 2.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company’s stock worth $104,280,000 after acquiring an additional 25,004 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Stock Performance

HQY stock opened at $90.19 on Wednesday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The business’s 50-day moving average price is $104.40 and its two-hundred day moving average price is $95.94. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The firm has a market cap of $7.80 billion, a PE ratio of 82.74, a P/E/G ratio of 1.60 and a beta of 0.62.

Wall Street Analysts Forecast Growth

HQY has been the topic of several recent research reports. KeyCorp decreased their price target on HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Monday. Mizuho started coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. Barrington Research reissued an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research note on Friday, March 14th. Wells Fargo & Company raised their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Finally, Royal Bank of Canada upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, HealthEquity currently has an average rating of “Buy” and a consensus target price of $113.31.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.